Efficacy of camptothecin in progressive multifocal leucoencephalopathy.
Vollmer-Haase
J
J
Young
P
P
Ringelstein
E B
EB
D000328:Adult; D002166:Camptothecin / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000009:adverse effects; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007968:Leukoencephalopathy, Progressive Multifocal / Q000139:chemically induced / Q000188:drug therapy*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D059004:Topoisomerase I Inhibitors
D007166:Immunosuppressive Agents; D059004:Topoisomerase I Inhibitors; D003520:Cyclophosphamide; D002166:Camptothecin